Ubs Group Ag Seagen Inc. Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$191.51 - $216.16 $2.57 Million - $2.9 Million	13,424 Added 26.31%	64,453 $13.7 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $12.7 Million - $14 Million	-67,849 Reduced 57.07%	51,029 $9.82 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $8.67 Million - $13.8 Million	-67,958 Reduced 36.37%	118,878 $24.1 Million
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $13 Million - $15.4 Million	110,849 Added 145.88%	186,836 $24 Million
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $1.28 Million - $1.7 Million	-9,429 Reduced 11.04%	75,987 $10.4 Million
Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $1.53 Million - $2.52 Million	14,061 Added 19.71%	85,416 $15.1 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $14.3 Million - $18.9 Million	-119,517 Reduced 62.62%	71,355 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $5.2 Million - $6.96 Million	36,454 Added 23.61%	190,872 $29.5 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $13.4 Million - $15.9 Million	93,897 Added 155.15%	154,418 $26.2 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $8.8 Million - $10.5 Million	-65,119 Reduced 51.83%	60,521 $9.56 Million
Q1 2021 May 12, 2021	BUY	$137.51 - $190.8 $67,654 - $93,873	492 Added 0.39%	125,640 $17.4 Million
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $20.6 Million - $26.5 Million	125,148 New	125,148 $21.9 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.